Clinical Trials on IMMUNOTHERAPY

Total 260 results

Ajou University School of Medicine

Completed

Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG

Immunotherapy

Korea, Republic of
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study

Immunotherapy

China
Centre Georges Francois Leclerc
AstraZeneca

Active, not recruiting

Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment (GUIDE2REPAIR)

Immunotherapy

France
Anhui Provincial Hospital

Unknown

NK Cells Infusion for Advanced Malignancies

Immunotherapy

China
Power Life Sciences Inc.

Not yet recruiting

Investigating The Experiences of Patients In Immunotherapy Clinical Trials

Cancer | Immunotherapy
Xuanwu Hospital, Beijing

Recruiting

A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

Immunotherapy | ADR

China
Rutgers, The State University of New Jersey
Pfizer; American Cancer Society, Inc.

Completed

Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy (PINPOINT)

Immunotherapy | Clinical Trials

United States
Peking University First Hospital
YiZhou International Cancer Hospital

Unknown

Combination of Hypofractionated Proton Therapy With Immunotherapy (I-HypoPT)

Immunotherapy | Proton Therapy
Nanfang Hospital, Southern Medical University

Recruiting

Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

Immunotherapy | Biomarker | Hyperprogression

China
Peking University First Hospital

Not yet recruiting

Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors

Immunotherapy | SBRT | Bulky Tumor
University of Erlangen-Nürnberg Medical School
Wuerzburg University Hospital; University Hospital Regensburg

Recruiting

Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy (PROMIT)

Immunotherapy

Germany
National Taiwan University Hospital

Active, not recruiting

Patient Care Needs and the Decision-Making Experience of Patients With Cancer and Family Caregivers Regarding Immunotherapy: A Qualitative and Quantitative Mixed Methods Study

Immunotherapy | Supportive Care Needs

Taiwan
Xinqiao Hospital of Chongqing

Recruiting

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

Artificial Intelligence | Malignant Tumor | Immunotherapy

China
Valérie LAURENT

Completed

CT Perfusion Parameters for Advanced HCC Treated by Systemic Immunotherapy

Advanced HCC Treated by Systemic Immunotherapy

France
University Health Network, Toronto

Active, not recruiting

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

Advanced Cancer | Immunotherapy | Radiation Therapy | Palliative

Canada
Ankara Medipol University

Recruiting

The Effect of Education and Telephone Follow-up Given to Cancer Patients Receiving Immunotherapy on Symptom Management and Self-care Power

Self Care | Immunotherapy | Symptom Management | Cancer Patient

Turkey
Centre Francois Baclesse

Completed

Study of the Cognition of Patients Treated With Immunotherapy (COG-IMMUNO)

Patients With Cancer Who Start Immunotherapy | All Neoplasms

France
Second Affiliated Hospital of Guangzhou Medical...
Hunan Zhaotai Yongren Medical Innovation Co. Ltd.

Recruiting

Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

Anti-cancer Cell Immunotherapy | T Cell and NK Cell

China
Michael Scharl

Recruiting

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

Cancer | Immunotherapy | Immune Checkpoint Inhibitors | Fecal Microbiota Transplantation

Switzerland
Centre Hospitalier Universitaire, Amiens
Central Hospital Saint Quentin

Recruiting

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment (Ibe2i-TIPCI)

Immunotherapy | Immune Checkpoint Inhibitors | Immune-related Adverse Event | Predictive Biomarkers

France
Kafkas University

Completed

Effect of Z Technıque on Pain, Comfort, Symptoms in Ummunotherapy Areas

Immunotherapy

Turkey
Hellenic Cooperative Oncology Group

Completed

Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease (CIAD)

Autoimmune Diseases | Immunotherapy | Checkpoint Inhibitor

Greece
The University Clinic of Pulmonary and Allergic...

Unknown

Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions

Allergy | Immunotherapy | Omalizumab | Bee Venom

Slovenia
Nanfang Hospital of Southern Medical University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients (PANORAMA)

Chemotherapy | Immunotherapy

China
Viome
AdventHealth

Recruiting

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Gynecologic Cancer | Immunotherapy | Gut Microbiome

United States
West China Hospital

Recruiting

Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC

Immunotherapy | SBRT | Stage IV HCC

China
Mahidol University

Active, not recruiting

Immunological Response After Shrimp Oral Immunotherapy Treatment

Immunotherapy | Allergy to Shrimp

Thailand
Chuangzhen Chen

Recruiting

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors (ILDRV1)

Radiotherapy | Immune Checkpoint Blockade | Metastatic Extracranial Malignant Solid Neoplasm | Resistance to Immunotherapy

China
Johann Wolfgang Goethe University Hospital
Allergopharma GmbH & Co. KG

Completed

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

Immunotherapy

Germany
Guangdong Association of Clinical Trials

Recruiting

The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Lung Cancer | Immunotherapy

China
Nemours Children's Clinic

Completed

Evaluation of Pain Alleviating Strategies During Allergy Shots (PPAST)

Allergy | Immunotherapy

United States
Mahidol University

Recruiting

Comparison Efficacy Between Two Different Frequency of Maintenance Dose Oral Immunotherapy

Immunotherapy | Wheat Hypersensitivity

Thailand
University Hospital, Montpellier

Completed

Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice (CHOICE)

Allergen Immunotherapy

France
Shanghai Juncell Therapeutics
Sir Run Run Shaw Hospital

Recruiting

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Advanced Solid Tumor | Treatment Side Effects | Effects of Immunotherapy | Tumor Infiltrating Lymphocytes

China
Baodong Qin

Unknown

Effect of Chemotherapy on PD-L1 in NSCLC

Chemotherapy | Immunotherapy | PD-L1

China
University Hospital, Grenoble
Jules Bordet Institute

Completed

Cancer Patients Treated With Immunotherapy in Intensive Care Unit (IMMUNO-REA)

Cancer | Critical Illness | Immunotherapy

Belgium, France
Shanghai International Medical Center

Unknown

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Chemotherapy | Advanced Malignancies | Precision Cell Immunotherapy

China
The Netherlands Cancer Institute

Completed

ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (IMCISION)

Head and Neck Neoplasms | Immunotherapy

Netherlands
University Hospital Center of Martinique
European Georges Pompidou Hospital

Completed

Changes in the Microenvironment of HPV-induced Head and Neck Cancers in West Indies and Metropolitan Population (MituHPV)

Immunotherapy

France, Martinique
Chinese PLA General Hospital

Completed

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Psoriasis | Adoptive Immunotherapy

China
Guangzhou FineImmune Biotechnology Co., LTD.

Recruiting

Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors (TAL-T)

Advanced Solid Tumor | Immunotherapy | Tumor Associated Lymph Node T Cell

China
Hospices Civils de Lyon

Unknown

ASIA Study : French Register of Inflammatory Eye Disease (ASIA)

Patients Treated for Cancer by Immunotherapy

France
Peking University First Hospital
YiZhou International Cancer Hospital

Unknown

Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer (PI-MMC)

Neoplasm Metastasis | Immunotherapy | Proton Therapy
Second Affiliated Hospital of Nanchang University

Recruiting

Phase II, Single-arm Exploratory Clinical Study of Tislelizumab Combined With Anlotinib in the Treatment of Advanced Pulmonary Pleomorphic Carcinoma

Immunotherapy | Tislelizumab | Pulmonary Pleomorphic Carcinoma

China
Philippe Bégin
The Hospital for Sick Children; Centre de recherche du Centre hospitalier universitaire... and other collaborators

Recruiting

Omalizumab to Accelerate a Symptom-driven Multi-food OIT (BOOM)

Immunotherapy | Physiological Effects of Drugs | Food IgE-mediated Allergy | Omalizumab

Canada
The Second Hospital of Shandong University

Recruiting

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

Esophageal Cancer | Immunotherapy | Gastroesophageal Cancer | Adjuvant

China
Sun Yat-sen University
The First Affiliated Hospital of Guangzhou Medical University; Sixth Affiliated...

Recruiting

RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial (RAMEC)

Hepatectomy | Primary Liver Cancer | Immunotherapy | Radiofrequency Ablation

China
Second Affiliated Hospital of Zunyi Medical University
Guizhou Provincial People's Hospital; The First People's Hospital of Zunyi; Guizhou... and other collaborators

Recruiting

Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC

Immunotherapy | Second-line Treatment

China
Michael Dill
University of Cologne; German Cancer Research Center; Heidelberg University; Universitätsmedizin... and other collaborators

Not yet recruiting

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) (FLORA)

Immunotherapy

Germany
Assaf-Harofeh Medical Center

Unknown

Predictors of Positive Food Challenge

Oral Immunotherapy for Food Allergy

Israel

Clinical Trials on IMMUNOTHERAPY

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations